About GEMNS

The incidence of lung cancer continues to rise worldwide. In Europe, among the European Community countries, cancer of the lung remains the leading cancer site in men. Among woman the mortality from lung cancer recently exceeds that from breast carcinoma. Therefore, the near future of personalized medicine lies in the development of multifunctional nanoparticles that can not only deliver desired therapeutics to specific molecular targets in cancer, but also treat and allow real-time monitoring of treatment with relevant imagining modalities. Read More
GEMNS project has a strong position in the emerging field of nanotechnology and nanomedicine that has a high potential for technological and conceptual breakthroughs, innovation and creation of fully innovative graphene-encapsulated magnetic nanoparticles

News

See More